CN102258713A - Chinese medicinal composition for preventing and treating metabolic diseases - Google Patents
Chinese medicinal composition for preventing and treating metabolic diseases Download PDFInfo
- Publication number
- CN102258713A CN102258713A CN2010101866747A CN201010186674A CN102258713A CN 102258713 A CN102258713 A CN 102258713A CN 2010101866747 A CN2010101866747 A CN 2010101866747A CN 201010186674 A CN201010186674 A CN 201010186674A CN 102258713 A CN102258713 A CN 102258713A
- Authority
- CN
- China
- Prior art keywords
- percent
- medicinal materials
- radix
- root
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for preventing and treating metabolic diseases, which consists of active ingredients and/or pharmaceutical auxiliary components, and is characterized in that: the active ingredients are prepared from raw materials which are the following five classes of medicinal materials in percentage by weight: 1, Qi circulation promoting medicinal materials (3 to 30 percent) including areca nut, officinal magnolia bark, immature bitter orange, old stem of wrinkled gianthyssop herb, caulis perllae and full trichosanthes kirilowii maxim; 2, heat clearing medicinal materials (3 to 60 percent) including coptis chinensis, scutellaria baicalensis, cape jasmine, honeysuckle, root of rehmannia and dwarf lilyturf tuber; 3, phlegm and dampness eliminating medicinal materials (6 to 60 percent) including pinellia tuber, eupatorium, white silkworm, thunberg fritillary bulb, coix seed and dried tangerine peel; yang warming and cold dispelling medicinal materials (1 to 10 percent) including cinnamon, tetradium ruticarpum and prepared common monkshood daughter root; and 5, blood circulating medicinal materials (6 to 60 percent) including root of red-rooted salvia, red paeony root, peach seed, hiraute shiny bugleweed herb and safflower. The Chinese medicinal composition has the effects of promoting qi circulation, relieving stomach swelling, clearing heat, reducing phlegm, dispersing by acrid, reducing fire by bitter taste, harmonizing the stomach, eliminating the dampness, and promoting blood circulation. The Chinese medicinal composition can be used for preventing and treating metabolic syndrome, obesity, pathoglycemia/dyslipidemia, uric acid increase and the like.
Description
Technical field: medical science or biomedicine
Background technology: national Eleventh Five-Year Plan supporting plan " the comprehensive behavior intervention technical research of MS " is divided on problem " the Chinese medicine intervention techniques research of the MS " basis, find by 527 routine MS Syndrome in TCM Hou Xue investigation, core-the abdominal obesity of MS and the traditional Chinese medical science " fullness in the epigastrium and abdomen " match, MS is divided into " real in the fullness in the epigastrium and abdomen " and " fullness in the epigastrium and abdomen interior-deficiency " two fundamental types, wherein belong to " real in the fullness in the epigastrium and abdomen " person's 435 examples, account for 82.5%, occupy most, core pathogenesis for MS, " fullness in the epigastrium and abdomen expectorant heat " is basic card marquis, " circulation of qi promoting is loose full; removing heat-phlegm " is the basic rule of treatment, created generation and combined the side, accompanying the disorder of light moderate glycolipid with first visit MS is object of study, and 109 examples are met the patient that MS diagnosed and included in standard, adopt multicenter, at random, the placebo clinical research, confirm that " comprehensive side of generation " can reduce waistline, on an empty stomach and 2 hours after the meal blood glucose and triglyceride, high density lipoprotein increasing relatively has significant difference (P＜0.05 or 0.01) with matched group.
Summary of the invention: the new theory of Chinese medicine metabolism syndrome---" real in the fullness in the epigastrium and abdomen " mainly demonstrate,proved marquis's " fullness in the epigastrium and abdomen expectorant heat "
New recipe---in generation, combined the side;
Novel drugs is formed and medicine compatibility method---qi-activating drug and antipyretic compatibility, antipyretic and apophlegmatisant compatibility, apophlegmatisant and damp eliminating medicine compatibility, antipyretic and cold expelling medicine compatibility; Various kinds of drug and blood circulation promoting medicine compatibility.
The present invention is the Chinese medicine composition of a kind of prevention and treatment metabolism syndrome, it is made up of effective ingredient and/or pharmaceutic adjuvant, it is characterized in that wherein preparing the five big class medical materials that described raw materials of effective components contains the following weight proportioning: 1. qi-activating drug (3-30%): Semen Arecae, Cortex Magnoliae Officinalis, Fructus Aurantii Immaturus, Herba agastaches, Caulis Perillae, Fructus Trichosanthis; 2. antipyretic (3-60%): Rhizoma Coptidis, Radix Scutellariae, Fructus Gardeniae, Flos Lonicerae, the Radix Rehmanniae, Radix Ophiopogonis; 3. dispelling phlegm and eliminating dampness medicine (6-60%): the Rhizoma Pinelliae, Herba Eupatorii, Bombyx Batryticatus, Bulbus Fritillariae Thunbergii, Semen Coicis, Pericarpium Citri Reticulatae; 4. warming YANG to expel cold medicine (1-10%): Cortex Cinnamomi, Fructus Evodiae, Radix Aconiti Lateralis Preparata; 5. blood circulation promoting medicine (6-60%): Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Semen Persicae, Herba Lycopi, Flos Carthami.The present invention has the effect that circulation of qi promoting is loose full, removing heat-phlegm, pungent drugs can disperse and bitter drugs can descend, stomach function regulating damp eliminating, invigorated blood circulation.Be used for prevention or treatment metabolism syndrome, obesity, blood glucose and or dyslipidemia, uric acid disease such as increase.
Description of drawings: do not have
The specific embodiment: (1) be applied to prevention or treatment metabolism syndrome, obesity, blood glucose and or dyslipidemia, uric acid disease such as increase.
(2) new drug compound recipe exploitation;
(3) separation of active substance, effective site, active component, effective ingredient and the research of extraction original new drug
Claims (1)
1. the Chinese medicine composition of treatment and prevention of metabolic syndrome, it is made up of effective ingredient and/or pharmaceutic adjuvant, wherein prepare five big class medical material, the 1. qi-activating drugs (3-30%) that raw materials of effective components contains the following weight proportioning: Semen Arecae, Cortex Magnoliae Officinalis, Fructus Aurantii Immaturus, Herba agastaches, Caulis Perillae, Fructus Trichosanthis; 2. antipyretic (3-60%): Rhizoma Coptidis, Radix Scutellariae, Fructus Gardeniae, Flos Lonicerae, the Radix Rehmanniae, Radix Ophiopogonis; 3. dispelling phlegm and eliminating dampness medicine (6-60%): the Rhizoma Pinelliae, Herba Eupatorii, Bombyx Batryticatus, Bulbus Fritillariae Thunbergii, Semen Coicis, Pericarpium Citri Reticulatae; 4. warming YANG to expel cold medicine (1-10%): Cortex Cinnamomi, Fructus Evodiae, Radix Aconiti Lateralis Preparata; 5. blood circulation promoting medicine (6-60%): Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Semen Persicae, Herba Lycopi, Flos Carthami.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101866747A CN102258713A (en) | 2010-05-31 | 2010-05-31 | Chinese medicinal composition for preventing and treating metabolic diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101866747A CN102258713A (en) | 2010-05-31 | 2010-05-31 | Chinese medicinal composition for preventing and treating metabolic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102258713A true CN102258713A (en) | 2011-11-30 |
Family
ID=45005679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101866747A Pending CN102258713A (en) | 2010-05-31 | 2010-05-31 | Chinese medicinal composition for preventing and treating metabolic diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102258713A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102512648A (en) * | 2011-12-28 | 2012-06-27 | 张清辉 | Traditional Chinese drug composition for treatment and prevention of metabolic syndrome |
| CN110898170A (en) * | 2018-09-17 | 2020-03-24 | 江苏九旭药业有限公司 | Traditional Chinese medicine composition for treating metabolic syndrome and preparation thereof |
| RU2780451C1 (en) * | 2018-09-17 | 2022-09-23 | Цзянсу Цзюсюй Фармасьютикал Ко., Лтд. | Composition based on medicinal materials of traditional chinese medicine for treatment of metabolic syndrome, its production method and use, and pharmaceutical drug based on it and its use |
-
2010
- 2010-05-31 CN CN2010101866747A patent/CN102258713A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102512648A (en) * | 2011-12-28 | 2012-06-27 | 张清辉 | Traditional Chinese drug composition for treatment and prevention of metabolic syndrome |
| CN102512648B (en) * | 2011-12-28 | 2014-07-23 | 张清辉 | Traditional Chinese drug composition for treatment and prevention of metabolic syndrome |
| CN110898170A (en) * | 2018-09-17 | 2020-03-24 | 江苏九旭药业有限公司 | Traditional Chinese medicine composition for treating metabolic syndrome and preparation thereof |
| WO2020057503A1 (en) * | 2018-09-17 | 2020-03-26 | 睢宁九旭神州医药科技有限公司 | Traditional chinese medicine composition for treating metabolic syndrome and preparations thereof |
| CN110898170B (en) * | 2018-09-17 | 2022-04-05 | 江苏九旭药业有限公司 | Traditional Chinese medicine composition for treating metabolic syndrome and preparation thereof |
| RU2780451C1 (en) * | 2018-09-17 | 2022-09-23 | Цзянсу Цзюсюй Фармасьютикал Ко., Лтд. | Composition based on medicinal materials of traditional chinese medicine for treatment of metabolic syndrome, its production method and use, and pharmaceutical drug based on it and its use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103768537A (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN104758487A (en) | Traditional Chinese medicine composition for treating exfoliative cheilitis | |
| CN102397351A (en) | Traditional Chinese medicinal composition for treating insomnia | |
| CN102451334B (en) | Decoction for treating canker sore | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN104147502A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of traditional Chinese medicine composition | |
| CN105685963A (en) | Dendrobium officinale kimura ex migo digestion aiding tablet and preparation method thereof | |
| CN102370727A (en) | Compound Chinese medicinal preparation for treating depression and preparation method thereof | |
| CN101653519A (en) | Chinese medicament composition for preventing and treating chicken fatty liver hemorrhagic syndrome and preparation method thereof | |
| CN105311572A (en) | Medicine for treating chronic gastritis | |
| CN103301363B (en) | Pharmaceutical composition for treating upper gastrointestinal hemorrhage | |
| CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
| CN102258713A (en) | Chinese medicinal composition for preventing and treating metabolic diseases | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
| CN103705731B (en) | A kind of Chinese medicine composition for the treatment of chronic alcoholic toxic liver disease | |
| CN102451458A (en) | Traditional Chinese medicine formula for treating chronic pyelonephritis | |
| CN101375962B (en) | Formulation for activating blood and freeing collateral vessels and preparation method thereof | |
| CN103784690B (en) | One treats cardiopathic Chinese medicine composition | |
| CN103751688B (en) | A kind of Chinese herbal medicine for the treatment of gastropathy and preparation method thereof | |
| CN102078494A (en) | Hemostatic pharmaceutical composition and preparation method thereof | |
| CN101129654A (en) | Orally taken traditional Chinese medicine for treating cerebral hemorrhage sequela | |
| CN105079622A (en) | Medicine applied to treatment of acne and preparation method of medicine | |
| CN105079580A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111130 |